Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

Executives Sell More Than $220M Of 3 Stocks

Amgen United States Dutch Bros Dutch Bros Inc Nasdaq Rivian Automotive Inc

US stock futures traded higher on this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Rivian Automotive

  • The Trade: Rivian Automotive, Inc. (NASDAQ:RIVN) 10% owner Ford Motor Co sold a total of 8,000,000 shares at an average price of $26.80. The insider received around $214.14 million from selling those shares.
  • What’s Happening: Rivian agreed to build electric vehicle manufacturing plant in Georgia.
  • What Rivian Automotive Does: Rivian Automotive Inc designs, develops and manufactures category-defining electric vehicles and accessories.

Dutch Bros

  • The Trade: Dutch Bros Inc. (NYSE:BROS) CEO and President Joth Ricci sold a total of 71,125 shares at an average price of $42.47. The insider received around $3.02 million from selling those shares.
  • What’s Happening: Dutch Bros will report financial results for the first quarter after the closing bell today.
  • What Dutch Bros Does: Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages.

Also check this: 4 Stocks Under $3 Insiders Are Aggressively Buying

Amgen

  • The Trade: Amgen Inc. (NASDAQ:AMGN) EVP, Gen. Counsel & Secy. Jonathan P Graham sold a total of 13,500 shares at an average price of $241.81. The insider received around $3.26 million as a result of the transaction.
  • What’s Happening: Mizuho maintained Amgen with a Neutral and raised the price target from $202 to $208.
  • What Amgen Does: Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases.

Have a look at our premarket coverage here .

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
John Krasinski Named People Magazine's Sexiest Man Alive 2024
John Krasinski named Sexiest Man Alive 2024 by People magazine, known for versatile acting career and humor.
Top News
Top News
Kids Refuse To Attend Family Functions Over Who They Voted For: “Condone Lying And Cheating”
Research indicates that the presidential election is a huge source of stress and is causing many people to spend less time with their relatives. The post Kids Refuse To Attend Family Functions Over Who They Voted For: “Condone Lying And Cheating” first appeared on Bored Panda.
Bored Panda
Bored Panda
Roy Haynes, jazz drummer whose career spanned nine decades, dies aged 99
American drummer who began in 1940s swing and bebop scenes played with Charlie Parker, John Coltrane and dozens more
The Guardian - UK
The Guardian - UK
Most US book bans target children’s literature featuring diverse characters and authors of color
Book bans in U.S. schools and libraries during the 2021-22 school year disproportionately targeted children’s books written by people of color – especially women of color – according to a peer-reviewed study we published. They also tended to feature characters of color.
The Conversation
The Conversation
What is oncom?
"An Indonesian staple is shaking up the restaurant scene and may just end up preventing a big source of emissions"
Salon
Salon
Cut Back On Makeup During Pregnancy, Lactation: Study Links Increased Use To Harmful PFAS
The study warns that increased use of personal care products during pregnancy and nursing is linked to higher levels of harmful chemicals such as per- and polyfluoroalkyl substances (PFAS) in the blood plasma and breast milk.
Medical Daily
Medical Daily
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
Download on the AppStore Get it on Google Play